Literature DB >> 31181453

Free enzyme dynamics of CmaA3 and CmaA2 cyclopropane mycolic acid synthases from Mycobacterium tuberculosis: Insights into residues with potential significance in cyclopropanation.

David Annaraj P1, Priyadarsini Kadirvel1, Ahalyaa Subramanian1, Sharmila Anishetty2.   

Abstract

Mycolic acids are long chain alpha-alkyl beta-hydroxy fatty acids that are major constituents of the cell wall of Mycobacterium tuberculosis. M. tuberculosis produces three main types of mycolic acids, alpha mycolic acids and keto and methoxy mycolic acids. Cycloproponated mycolic acids make the cell wall less permeable, contribute to antibiotic resistance and host immunomodulation and protect from injury. Cyclopropanation is catalyzed by enzymes of the Cyclopropane Mycolic Acid Synthase (CMAS) family. In the current study, we addressed two CMAS enzymes, proximal alpha cyclopropane mycolic acid synthase (PcaA/CmaA3) and keto cyclopropane Mycolic acid synthase (CmaA2). All-atom Molecular Dynamics (MD) simulations were performed for these enzymes for a timeframe of 100ns each (in triplicate), using GROMACS. Based on the PDB structures of apo and holo states of related CMAS enzymes, we generated a framework which helped us correlate active or inactive states of the enzymes to different conformations sampled by the enzymes during MD simulations. Dynamics suggested that the free or unbound enzymes have intrinsic memory and sample different states of catalysis even in the absence of the substrate/cofactor. Additionally, we find that F200, P201 and W204 may have functional significance. MD simulation of CmaA2 was performed with the objective of gaining insights into the putative role of a loop insert. Analysis showed that acidic residues of this loop possibly play an important role during the active state by forming salt bridges. The insights gained in this study can potentially be utilized for design of effective inhibitors against CMAS enzymes.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CmaA2; Drug targets; Free enzyme dynamics; MD simulation; PcaA/CmaA3; Salt bridges

Mesh:

Substances:

Year:  2019        PMID: 31181453     DOI: 10.1016/j.jmgm.2019.05.016

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  2 in total

1.  Screening of Microbial Fermentation Products for Anti-M. tuberculosis Activity.

Authors:  Aikebaier Reheman; Di Lu; Yifan Wang; Xi Chen; Gang Cao; Chuanxing Wan
Journal:  Animals (Basel)       Date:  2022-07-31       Impact factor: 3.231

2.  Fragment-Based Ligand Discovery Applied to the Mycolic Acid Methyltransferase Hma (MmaA4) from Mycobacterium tuberculosis: A Crystallographic and Molecular Modelling Study.

Authors:  Romain Galy; Stéphanie Ballereau; Yves Génisson; Lionel Mourey; Jean-Christophe Plaquevent; Laurent Maveyraud
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.